Avanos Medical Inc

AVNS

13.520USD

-0.310-2.24%

Close 03/27, 16:00（ET）Quotes delayed by 15 min

Avanos Medical Inc's Score

Industry at a Glance

Industry Ranking

47 / 208

Overall Ranking

141 / 4542

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative

Avanos Medical Inc Highlights

StrengthsRisks

Avanos Medical, Inc. is a medical technology company focused on delivering medical device solutions. It offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. Specialty Nutrition Systems portfolio of products includes enteral feeding, which consist of MIC-KEY enteral feeding tubes and Corpak patient feeding solutions, and Neonate solutions feeding products consist of NeoMed neonatal and pediatric feeding solutions. It also includes TKO, an anti-reflux needleless connector technology, which is used in Neonatal and Pediatric Intensive Care Units. The Pain Management and Recovery portfolio of products includes surgical pain and recovery products such as ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems and Radiofrequency Ablation solutions, which provide invasive pain relief therapies, such as COOLIEF, Trident and ESSENTEC RFA products.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 701.20M.

Fairly Valued

The company’s latest PE is -8.59, at a medium 3-year percentile range.

Institutional Buying

The latest institutional holdings are 44.88M shares, increasing 0.01% quarter-over-quarter.

Held by CI Select Canadian Equity Fund

Star Investor CI Select Canadian Equity Fund holds 487.00 shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 1.26.

Analyst Rating

Based on 1 analysts

Hold

Current Rating

14.000

Target Price

+13.73%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current financial score of Avanos Medical Inc is 6.49, ranking 145 out of 208 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 180.90M, representing a year-over-year increase of 0.72%, while its net profit experienced a year-over-year increase of 99.67%.

Score

Industry at a Glance

Previous score

6.49

Change

0



Financials

8.01

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

2.46

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

7.81

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

7.02

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.15

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

The current valuation score of Avanos Medical Inc is 9.00, ranking 1 out of 208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -8.59, which is -1871.73% below the recent high of 152.14 and -297.60% above the recent low of -34.14.

Score

Industry at a Glance

Previous score

9.00

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 47/208

Relevant data have not been disclosed by the company yet.

The current earnings forecast score of Avanos Medical Inc is 6.00, ranking 175 out of 208 in the Healthcare Equipment & Supplies industry. The average price target is 14.00, with a high of 14.00 and a low of 14.00.

Score

Industry at a Glance

Previous score

6.00

Change

0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current price momentum score of Avanos Medical Inc is 7.07, ranking 35 out of 208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 14.28 and the support level at 12.76, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

8.64

Change

-1.57

Support & Resistance

Relevant data have not been disclosed by the company yet.

Institutional Confidence

Currency: USD Updated: 2026-03-27

The current institutional shareholding score of Avanos Medical Inc is 10.00, ranking 1 out of 208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 113.89%, representing a quarter-over-quarter decrease of 0.44%. The largest institutional shareholder is The Vanguard, holding a total of 3.45M shares, representing 7.42% of shares outstanding, with 35.07% decrease in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

6.15M

-1.34%

T. Rowe Price Investment Management, Inc.

4.71M

+17.94%

The Vanguard Group, Inc.

Star Investors

3.36M

-23.62%

Armistice Capital LLC

2.50M

+22.79%

Dimensional Fund Advisors, L.P.

2.35M

-8.74%

State Street Investment Management (US)

1.90M

-0.85%

Brown Advisory

2.23M

+23.10%

D. E. Shaw & Co., L.P.

1.30M

+8.99%

Geode Capital Management, L.L.C.

1.07M

-0.61%

Charles Schwab Investment Management, Inc.

863.95K

+30.01%



1

2



The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Avanos Medical Inc is 6.96, ranking 48 out of 208 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.07. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.

Avanos Medical Inc

AVNS

7.28 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Thermo Fisher Scientific Inc

TMO

8.39 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Bioventus Inc

BVS

8.28 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Anika Therapeutics Inc

ANIK

8.13 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Lantheus Holdings Inc

LNTH

8.07 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Edwards Lifesciences Corp

EW

8.05 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment